Clinical trial
High Dose Chemotherapy Followed By PBSC Rescue for HD
NCT00186251 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00186251 |
|---|---|
| Title | High Dose Chemotherapy Followed By PBSC Rescue for HD |
| Official title | Use of High Dose Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Relapsed or Resistant Hodgkin's Disease |
| Lead sponsor | Stanford University, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Hodgkin Disease |
| Intervention type | Procedure |
| Interventions | high dose chemo then auto hematopoietic cell transplant |
| Enrollment | 200 |
| Start date | Mar 1, 1998 |
| Completion | Jul 1, 2005 |
| First posted | Sep 16, 2005 |
| Last update posted | Nov 12, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: